I t has been demonstrated, in various types of in vitro
experiments, that a low pH and the presence oflac tate in conventional dialysis solutions significantly contribute to their cytotoxicity. Exposure of neutrophils or peritoneal macrophages to such fluids results in a rapid lowering of their intracellular pH with subsequent deterioration of their function (1, 2) . Witowski et al demonstrated that exposure of human peritoneal mesothelial cells to dialysis fluid with a pH of 5.2 resulted in a dramatic decline in intracellular adenosine triphosphate (ATP) content, whereas this effect was not seen in cells exposed to the same fluid but with the pH adjusted to 7.3 (3) . We found that the combination of low pH and lactate decreases intracellular glutathione concentration in mesothelial cells, making them more susceptible to in jury by free radicals (4) .
Evidence of cytotoxicity of combined low pH and lactate has stimulated research into alternate buffer systems, such as those offering neutral pH and bicarbonate as the buffer. However, owing to the potential instability of bicarbonate solutions in the presence of calcium and magnesium, especially during autoclaving, two-chamber bags that separate these components are required (5) . In in vitro biocompatibility studies performed on human polymorphonuclear cells (6, 7, 8) , mesothelial cells (8) , and fibroblasts (9) , the superiority of neutral, bicarbonate-based dialysis fluids over acidic, lactate-based ones has been clearly demonstrated. In addition, bicarbonate/lactate-based dialysis fluids manufactured in two-chamber bags have lower concentrations of glucose degradation products compared with conventionallactate-based solutions manufactured in single-chamber bags (10) . Studies have shown that reduced levels of glucose degradation products present in such two-chamber bag designs contribute to their reduced in vitra cytotoxicity (7, 10) .
It has been, however, more difficult to demonstrate the superiority ofbicarbonate-based fluids in in viva conditions. Schambye et al could not show any difference in biocompatibility of neutral, bicarbonate-based dialysis fluid when compared to standard acidic, lactate-based solution over four weeks' evaluation in a rabbit model (11) . Gotloib et al have concluded that, based on their chronic studies in rats, the low pH of dialysate does not seem to playa decisive cytotoxic role in the in viva situation (12) . On the other hand, Di Paolo et al postulated that, both in animals and in humans, bicarbonate-based dialysis fluid better pre serves the production of phospholipids by the peritoneum compared to acidic, lactate-based counterparts (13) . In acute experiments in rabbits, Yatzidis demonstrated higher net ultrafiltration achieved with a bicarbonate glycylglycine dialysis solution compared to a respective lactate-based fluid (14) . Using an identical bicarbonate glycylglycine solution in rats, we found that, after one month of dialysis, peritoneal permeability to proteins was lower than in animals treated with standard lactate-based fluid (15) . In humans, Yamamoto et al showed improved ultra filtration during chronic dialysis with neutralized dialysis solution (16) , but these observations were not confirmed by others (17) . Recently published results from a multicenter study demonstrate that both bicarbonate and bicarbonate/lactate dialysis fluids reduced infusion pain in CAPD patients, with the latter solution being most effective (18) . In addition, ex viva human studies comparing bicarbonate-based solutions to conventional acidic, lactate formulations have shown improved peritoneal macrophage function and reduced levels of dialysate profibrotic markers, such as transforming growth factor &beta; (TGF&beta;) and procollagen, when exposed to the neutral pH, bicarbonate/lactate-based solutions (19, 20) .
In this paper, we present results from chronic experiments in rats that were dialyzed with two dialysis solution formulations: one with lactate 40 mmol/L and a low pH (5.2) , and the other a neutral pH formulation, containing a mixture of lactate 15 mmol/L and bicarbonate 25 mmol/L. After one month of dialysis, we evaluated peritoneal solute permeability, dialysate total cell count and differential, and dialysate levels of inflammatory mediators, both under unstimulated conditions and after in viva stimulation with endotoxin.
MATERIAL AND METHODS
Experiments were performed on male Wistar rats, weighing 300 -350 g. The animals were dialyzed during four weeks with two types of dialysis fluids: Compositions ofboth tested dialysis fluids are pre sented in Table 1 .
PROCEDURE OF CHRONIC PERITONEAL DIALYSIS IN RATS
Details of the technique of peritoneal dialysis in rats have been described previously (21) . Under ether anesthesia, in sterile conditions, the abdominal cavity was opened surgically and omentectomy was performed. Then, a silicone peritoneal dialy sis catheter (Dow Corning, Midland, Michigan, U.S.A.) was inserted into the abdominal cavity. The distal part of the catheter was translocated through the tunnel created with scissors under the skin of the abdomen and thorax. The exit site of the tunnel was located on the back of the rat's neck, between its ears. The catheter was fixed with two Dacron cuffs. The proximal cuff was attached with sutures to the abdominal muscles, at the site of catheter insertion, and the distal cuff was similarly attached to the skin, at the site of catheter exit on the neck.
Dialysis fluids (20 mL) were infused intraperitoneally via the implanted catheter twice daily, and the injected solutions were allowed to absorb from the peritoneal cavity. Dialysis solutions were supplemented with heparin (2500 U/L) and antibiotics (gentamycin 5 mg/L and cefuroxine 50 mg/L).
PERITONEAL EQUILIBRATION TEST (PET)
In each rat, after 1 month of dialysis, an 8-hour dwell exchange (30 mL) was performed with test dialysis fluidthe same fluid as that to which the animal had been exposed during the preceding 4 weeks (PET 1). Dialysate samples (2 mL) were taken at time 0 (instantly after infusion) and after 1 hour, 2 hours, 4 hours, and 8 hours of the dialysate dwell. During the PET, the animals were awake and unrestrained, with free access to drinking water and food. Mter an 8-hour dwell, the residual dialysate was drained by gravity, and then, under ether anesthesia, a blood sample from the tail vein was collected.
On the following day, a second PET was performed, but the dialysis solution was supplemented with 5 &mu;g/mL of E. coli, serotype 0111:B4, lipopolysaccharide (LPS) (Sigma, St. Louis, Missouri, U.S.A.), to induce an intraperitoneal inflammatory reaction (PET 2). Dialysate samples (2 mL) were taken at time intervals identical to those used during PET 1. After 8 hours, the residual fluid was drained and, under ether anesthesia, a blood sample from the tail vein was drawn. The animals were then sacrificed, the peritoneal cavity opened, and the residual dialysate volume collected with a Pasteur pipette.
EVALUATION OF THE PERITONEAL PERMEABILITY
Peritoneal permeability during PET was assessed by measuring the trans peritoneal equilibration of creatinine and of total protein: the dialysate-to-serum (D/S) ratio was calculated after 1 hour, 2 hours, and 4 hours of the dialysate dwell. Dissipation rate of the glucose load in the dialysate fluid was expressed by calculating the ratio of the dialysate glucose concentration after 1 hour, 2 hours, and 4 hours of the dialysate dwell to the initial concentration of glucose in the infused dialysis solution (D/Do).
Total protein concentrations in the dialysate samples and sera were measured using the Lowry method (22) . Creatinine concentrations were measured by the enzymatic method, using creatinase and creatininase, with a commercially available kit (Analco, Warsaw, Poland). Glucose concentrations in the dialysate samples were measured enzymatically (Sigma).
INFLAMMATORY PARAMETERS OF THE DIALYSATE
Cell count was measured in a hemocytometer using dialysate samples obtained at baseline (0 time), and after 1 hour,2 hours, 4 hours, and 8 hours of both PET 1 and PET 2. The differential count of the peri toneal cells was performed in Giemsa-stained (Sigma) smears obtained during cytospin. Mter reduction of nitrates to nitrites with nitrate reductase (Boehringer Mannheim, Mannheim, Germany), nitrite concentrations in the dialysate samples were measured with Griess reagent (23) . Sensitivityofthe nitrites assay in our laboratory was 0.75 &mu;mol/mL. Dialysate concentrations of tumor necrosis factor (TNF&alpha;), interleukin-l&beta; (IL-l&beta;), and interferon gamma (IFN -y) were measured with commercially available ELISA kits (Biosource, Camarillo, California, U.S.A.). Sensitivity of these assays when used in our laboratory was 2 pg/mL, 5 pg/mL, and 5 pg/mL, respectively.
STATISTICAL ANALYSIS
Results are presented as mean &plusmn; standard deviation. Statistical analysis of the data was performed with the Mann-Whitney test or with a two-way analysis ofvariance with repeated measurements (ANOVA). Post hoc Scheffe test was used to compare the differences between groups. A p value of less than 0.05 was considered significant.
RESULTS

PERITONEAL PERMEABILITY
After 4 weeks of peritoneal dialysis in rats, no consistent differences in the permeability of the peritoneum were found during PET 1 for neutral bicarbonate/ lactate-buffered dialysis solution compared with acidic lactate-buffered solution (Table 2) . Lower dialysate-toserum ratios of total protein concentration in the Bic -Lac group was an exception, but that difference was seen already at time 0.
During LPS-induced peritonitis, peritoneal solute transport was similar in both groups, but the volume of the drained dialysate after the 8 hour dwell of the tested dialysis fluids was greater in the Bic-Lac group: 6.1 &plusmn; 2.8 mL versus 3.4 &plusmn; 1.8 mL, respectively (p < 0.05).
DIALYSATE CELL COUNTS AND DIFFERENTIAL
Total cell counts in the dialysate were lower in the BicLac group compared to the Lac group, both during PET 1 (p < 0.02) and PET 2 (p < 0.01) (Figure 1 ). During PET 1, more macrophages (p < 0.001) and fewer neutrophils (p < 0.05) were observed in Bic -Lac dialysate than in the Lac dialysate (Table 3) . Also, during peritonitis, the number of macro phages was higher in the Bic-Lac group (p < 0.001) than in the Lac group, whereas the number of neutrophils was smaller (p < 0.001) ( Table 4) .
DIALYSATE CYTOKINE AND NITRITE CONCENTRATIONS
At time 0, during both PET 1 and PET 2, nitrites and cytokines were not detectable in the dialysate samples. During PET 1, in dialysate samples obtained after 8 hours of intraperitoneal dwell, the concentrations ofTNF&alpha;, IL-1&beta;, and IFN-ywere similar in both groups (Table  5) . However, nitrite concentrations in these samples were lower in the Bic -Lac group (Table 5) . Dialysate concentrations of all inflamma tory mediators were increased during peritonitis (Table 5) . Overall, TNF&alpha; and IFN -y concentrations in the dialysate were higher ( +53%, p < 0.05, and +303%, p < 0.02, respectively) in the Bic-Lac group as compared to the Lac group. However, when tested with the post hoc Scheffe test, the only significant difference for IFN-y was detected in the 8-hour dialysate sample (Table 5) .
DISCUSSION
Almost twenty years ago, Duwe and coworkers demonstrated, in their original experiments, the cytotoxic effect of commercial dialysis fluids to leukocytes (24) . Since that time, in various types ofin vitro experiments, low pH, the presence ofhigh concentrations oflactate, and the omission of bicarbonate (the natural buffer of the extracellular space), have all been demonstrated as important factors contributing to the bioincompatibility of conventional peritoneal dialysis solutions (5) . Results from in vitro experiments showing improved cell viability and function in the presence of dialysis fluid with neutral pH and reduced glucose degradation products, as achieved with bicarbonatebased, two-chamber bag systems, have prompted further exploration of the benefits of such formulations in vivo (25) . Confirmation of in vitro observations under in vivo conditions during chronic peritoneal dialysis, when the peritoneum is exposed repeatedly to such fluids for months, has begun using ex vivo cell function methodology and effluent analysis (26) .
In this paper, we have demonstrated that peritoneal solute permeability in rats exposed for four weeks to pHneutral bicarbonate/lactate-buffered dialysis fluid was similar to that in animals dialyzed w ith acidic lactatebuffered solution (Table 2) .
Lower dialysate-to-serum ratios of total protein concentration in the Bic -Lac group during PET 1 was observed at baseline (time 0), immediately after instillation of the dialysis fluid. This finding likely r eflects a lower protein concentration in the residual peritoneal fluid, possibly suggesting a state of reduced intraperitoneal inflammation in this Bic-Lac group as compared to the Lac group. This hypothesis is further supported by the reduced concentration of nitrites (Table 5) , the lower dialysate cell count (Figure 1) , and the higher ratio of macrophages to neutrophils (Table 3 ) seen in Bic -Lac dialysates compared to Lac dialysates. No significant differences in net ultrafiltration were seen between the groups during PET 1. During PET 1, we measured only the volumes of dialysate that were drained by gravity, without evaluation of the peritoneal residual volume. Therefore, these data do not provide definitive information about the effect of bicarbonate/lactate-buffered fluid on ultrafiltration.
However, during PET 2, both the drained volume of the dialysate and its residual volume were measured. The significantly higher volumes of residual dialysate in the Bic-Lac group may reflect a different degree of intraperitoneal inflammation in this group versus the Lac controls.
Mter one month of dialysis, we found lower dialy sate total cell counts in the Bic-Lac group, with a higher percentage of macrophages and a lower percentage of neutrophils when c ompared to the acidic Lac solution group. These findings further suggest that the Bic-Lac fluid induces a milder inflammatory reaction within peritoneal cavity. Bos et al have found an increased percentage of neutrophils in the effluent dialysate of non infected CAPD patients with time on dialysis, possibly reflecting a nonspecific peritoneal inflammatory reaction induced by dialysis (27) .
Our findings suggest that dialysis with neutral bicarbonate/lactate solution may prevent or slow the progress of that process.
Introduction ofnew dialysis fluids with neutral pH has been suggested as one of the main factors that could improve the function of peritoneal immunocompetent cells and subsequently reduce peritonitis rates (28) . Previous observations that more bio compatible fluids have a better ability to support growth of bacteria (29) were not confirmed in the case of bicarbonate-buffered solutions (8) . In our report, when intraperitoneal inflammation was induced by supplementation of the dialysis fluid with endotoxin, we observed that the increase in dialysate cell count was more pronounced in the Lac group (Figure 1) . Additionally, we observed differences in the composition of peritoneal cells present in the dialysate effluent obtained from the two study groups. In the Bic-Lac group, more macrophages and eosinophils were found in the dialysate samples, and the number of neutrophils was lower than in Lac group (Table  4 ). It is difficult to interpret how this difference in the peritoneal leukocyte population may influence the ability to eliminate bacteria invading the peritoneal cavity. It can be speculated that the increased number of macrophages might increase the efficiency of recognition, phagocytosis, and subsequent killing ofmicro organisms. In their human ex viva studies, Mackenzie et al could not detect similar changes in peritoneal effluent cell counts and differentials (19) . However, significant variability within and between patients was reported, which would make it harder to detect any true differences if they existed.
We observed significantly higher overall concentrations of TNF&alpha; and IFN-y in Bic -Lac dialysates during peritonitis as compared to Lac dialysates. The reason for such observed differences could include differences in the comp osition of the dialysate leukocyte population, or improved function of these cells after in viva incubation in fluid with neutral pH, or both. Previously, Sundaram and coworkers demonstrated that TNF&alpha; production by endotoxinstimulated peripheral blood mononuclear cells was higher in case of cells exposed to hypertonic, neutral, bicarbonate/lactate-buffered solution than by cells exposed to conventional acidic hypertonic fluid (7). They also observed improvement in phagocytosis and oxi dative burst in polymorphonuclear cells tested in the same conditions. These authors suggest that the beneficial effect of twochambered bicarbonate/lactatebuffered fluid on cell function was related to the reduction of glucose degradation products from heat sterilization of glucose in a separate chamber at a lower pH (7). Mackenzie et al found that TNF&alpha; production by peritoneal macrophages in viva, preincubated in the peritoneal cavity of CAPD patients in neutral bicarbonate/lactate-buffered solution, was significantly higher than by macro phages from the same patients but exposed in vivo to conventional acidic lactatebuffered fluid (19) . In the experimental animal model reported here, we simulated chronic dialysis for 4 weeks and also observed that peritoneal cells in vivo, stimulated with endotoxin, produced more pro-inflammatory mediators when exposed to Bic-Lac fluid, while decreasing their spontaneous levels in dialysate during unstimulated, normal dialysis conditions. An interesting observation is the strong stimula tion ofIFN-yproduction in Bic-Lac treated animals. IFNydialysate concentrations in these animals were increased almost 30 times when compared to fluid exchange without LPS, whereas in rats dialyzed with conventional acidic fluid, in viva stimulation with endotoxin caused only a sixfold increase in IFN-y dialysate levels. IFN -y is produced by stimulated lymphocytes and is essential for macrophage-mediated bactericidal effects; its concentration significantly increases during peritonitis (30). Lamperi et al found low IFN-yrelease by elicited peritoneal lymphocytes from CAPD patients with a high peritonitis incidence (31) . They showed that in vitro exposure of peritoneal macrophages from these patients to IFN -y improved macrophage function, and they suggested the use of that cytokine as a potential immunostimulator in CAPD patients. Calame et al demonstrated in rats that the addition ofIFN-yto dialysis fluid resulted in a significant increase in the number of peritoneal macrophages at the time of peritonitis induced by intraperitoneal inoculation of bacteria (32) . Production of nitrites by macrophages was increased and elimination of bacteria from the peritoneal cavity was more efficient (32) . In our experiments, an increased IFN-y concentration in the dialysate of the BicLac group was also concomitant with a higher percentage of macrophages. Whether higher levels of IFN -y and increased numbers of macrophages occur in the clinical setting remains to be fully investigated. Further studies in animals are needed to confirm if such changes contribute to better peritoneal elimination of bacteria.
In conclusion, we found that peritoneal solute permeability in rats dialyzed with neutral bicarbonate/ lactatebuffered dialysis fluid is not significantly different from that in animals exposed to conventional acidic dialysis solution. Lower dialysate cell counts and a smaller percentage ofneutrophils in the dialysate effluent from these animals may be an index of a diminished inflammatory reaction within the peritoneal cavity with the neutral bicarbonate/lactate-buffered solution. Upon stimulation with endotoxin, higher levels of dialysate cytokines in the bicarbonate/lactate group versus the lactate control group suggest an enhanced responsiveness of the perito neum and of the cells of the peritoneal cavity. Our findings support the thesis of improved biocompatibility of neutral bicarbonate-lactate dialysis fluids.
